Mindfulness Therapy for Insomnia
(Project WISHES Trial)
Trial Summary
Do I have to stop taking my current medications for the trial?
The trial does not specify if you need to stop taking your current medications. However, if you are taking more than one psychotropic medicine daily, you may not be eligible to participate.
What data supports the effectiveness of the treatment Mindfulness-based therapy for insomnia (MBTI)?
Research shows that Mindfulness-based therapy for insomnia (MBTI) can help improve sleep quality and reduce insomnia symptoms in older adults by decreasing the difference between how long they think it takes to fall asleep and how long it actually takes. This improvement is linked to increased mindfulness, which helps people become more aware and accepting of their thoughts and feelings, potentially leading to better sleep.12345
Is mindfulness therapy for insomnia safe for humans?
Mindfulness-based therapies for insomnia, like Mindfulness-Based Therapy for Insomnia (MBTI), have been studied in various trials and are generally considered safe for humans. These therapies focus on improving sleep through mindfulness practices and have not been associated with any significant safety concerns in the research available.12345
How is Mindfulness-based therapy for insomnia (MBTI) different from other treatments for insomnia?
Mindfulness-based therapy for insomnia (MBTI) is unique because it focuses on teaching mindfulness concepts through guided meditation and self-regulation practices, which help reduce cognitive arousal and improve sleep. Unlike traditional treatments like cognitive-behavioral therapy for insomnia (CBT-I), MBTI emphasizes mindfulness as a core component, offering an alternative approach for those who may not respond well to standard therapies.12467
What is the purpose of this trial?
The purpose of this study is to achieve health and healthcare equity by implementing an equity-focused, mindfulness-based sleep intervention to reduce stress and sleep deficiency-related cardiometabolic disease burden in Black women.
Research Team
Soohyun Nam, PhD, APRN, ANP-BC, FAHA, FAAN
Principal Investigator
Yale University School of Nursing
Eligibility Criteria
This trial is for Black women who are experiencing insomnia and may have cardiometabolic syndrome, which includes conditions like heart disease and diabetes. Participants should be interested in trying a mindfulness-based therapy to improve their sleep.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the online mindfulness-based therapy for insomnia (MBTI) intervention
Follow-up
Participants are monitored for changes in insomnia severity and perceived stress
Treatment Details
Interventions
- Mindfulness-based therapy for insomnia (MBTI)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
Department of Health and Human Services
Collaborator